ML Labs in US Aids drug trial
ML Laboratories, the biotechnology group, has begun a US trial for Viraldon, one of its Aids treatments, giving it greater access to seriously ill patients. UK trials of the treatment had been behind
ML Laboratories, the biotechnology group, has begun a US trial for Viraldon, one of its Aids treatments, giving it greater access to seriously ill patients. UK trials of the treatment had been behind